Insulin action enhancers for the management of Type 2 diabetes mellitus

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.7, 2000-12, pp. : 1413-1421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin Detemir: A Review of its Use in the Management of Type 1 and 2 Diabetes Mellitus

By Therese M. Chapman Caroline M. Perry

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2577-2595

Adis International

Access to resources Recommend Favorite

Insulin Glargine: A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus

By McKeage K. Goa K.L.

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1599-1624

Adis International

Access to resources Recommend Favorite

Insulin Aspart: A Review of its Use in the Management of Type 1 or 2 Diabetes Mellitus

By Reynolds Neil A. Wagstaff Antona J.

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1957-1974

Adis International

Access to resources Recommend Favorite

Defining the Role of Insulin Lispro in the Management of Postprandial Hyperglycaemia in Patients with Type 2 Diabetes Mellitus

By Giugliano D.

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 199-210

Adis International

Access to resources Recommend Favorite

Insulin Aspart: A Review of its Use in the Management of Type 1 and 2 Diabetes Mellitus

By Chapman T.M. Noble S. Goa K.L.

Drugs, Vol. 62, Iss. 13, 2002-01 ,pp. : 1945-1981

Adis International

Access to resources Recommend Favorite